A client has been prescribed potassium chloride (K-Dur) twice ...

[schs14]

A client has been prescribed potassium chloride (K-Dur) twice daily. What should the nurse teach the client regarding this medication?(Select all that apply.)
 
  1. Potassium chloride (K-Dur) is discontinued immediately if hyperkalemia is suspected.
  2. This medication is used to prevent high blood phosphate levels in patients who are on dialysis.
  3. This medication is used for the treatment of metabolic acidosis.
  4. Electrolyte levels should be frequently assessed.
  5. This medication is used to treat hyperglycemia.

Question 2

A client has been ordered to receive iron via IM administration. Which medication can be given either IM or IV?
 
  1. Ferrous fumarate (Feostat)
  2. Ferrous gluconate (Fergon)
  3. Ferrous sulfate (Feosol)
  4. Iron dextran (Dexferrum)

[honnalora]

Answer to Question 1

1, 4

Rationale 1: Electrolyte levels should be frequently assessed and the drug discontinued immediately if hyperkalemia is suspected.
Rationale 2: Calcium acetate (PhosLo) is given for high blood phosphate levels.
Rationale 3: Sodium bicarbonate is given to treat metabolic acidosis.
Rationale 4: Electrolyte levels should be frequently assessed and the drug discontinued immediately if hyperkalemia is suspected.
Rationale 5:Insulin is used to treat hyperglycemia.

Global Rationale: Electrolyte levels should be frequently assessed and the drug discontinued immediately if hyperkalemia is suspected. Calcium acetate (PhosLo) is given to prevent high blood phosphate levels. Sodium bicarbonate is given for metabolic acidosis. Insulin is used to treat hyperglycemia.

Answer to Question 2

4

Rationale 1: Ferrous fumarate (Feostat) is given PO.
Rationale 2: Ferrous gluconate (Fergon) is given PO.
Rationale 3: Ferrous sulfate (Feosol) is given PO.
Rationale 4:The IM/IV dose is individualized and determined from a table of correlations between the patient's weight and hemoglobin, per package insert.

Global Rationale: Iron dextram (Exferrum) can be given IM/IV. The dose is individualized and determined from a table of correlations between the patient's weight and hemoglobin, per package insert. Ferrous fumarate (Feostat), ferrous gluconate (Fergon), and ferrous sulfate (Feosol) are given PO.